updated 4/8/2011 7:16:43 AM ET 2011-04-08T11:16:43

NEW HAVEN, Conn., April 8, 2011 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that members of the executive team will present a company overview at the following upcoming investor conferences:

  • 18th Annual Future Leaders in the Biotech Industry Conference on Friday, April 15, 2011 at 11:30 a.m. EDT at the Millennium Broadway Hotel in New York City, NY;
     
  • Bank of America Merrill Lynch 2011 Health Care Conference on Wednesday, May 11, 2011 at 7:20 p.m. EDT at the Encore at Wynn in Las Vegas, NV; and
     
  • Noble Financial Capital Markets' Seventh Annual Equity Conference on Monday, May 16, 2011 at 1:00 p.m. EDT at the Hard Rock Hotel in Hollywood, FL.

The live audio broadcasts and the subsequent archived webcasts of the Company's presentations will be available on the Company's website, http://www.achillion.com, under the "News Center" section. The audio recording will be archived for 30 days following the live presentation. Please connect to Achillion's website several minutes prior to the start of the presentation to ensure adequate time for any software downloads that may be necessary.

About Achillion Pharmaceuticals

Achillion is an innovative pharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. Achillion's proven discovery and development teams have advanced multiple product candidates with novel mechanisms of action. Achillion is focused on solutions for the most challenging problems in infectious disease including hepatitis C and resistant bacterial infections. For more information on Achillion Pharmaceuticals, please visit www.achillion.com or call 1-203-624-7000.

CONTACT: Company Contact:
         Glenn Schulman
         Achillion Pharmaceuticals, Inc.
         Tel. (203) 624-7000
         gschulman@achillion.com
         
         Investors:
         Mary Kay Fenton
         Achillion Pharmaceuticals, Inc.
         Tel. (203) 624-7000
         mfenton@achillion.com
         
         Media:
         Christin Culotta Miller
         Ogilvy PR
         Tel. (212) 880-5264
         Christin.Miller@OgilvyPR.com

© Copyright 2012, GlobeNewswire, Inc. All Rights Reserved

Discuss:

Discussion comments

,

Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments

Data: Latest rates in the US

Home equity rates View rates in your area
Home equity type Today +/- Chart
$30K HELOC FICO 5.09%
$30K home equity loan FICO 5.19%
$75K home equity loan FICO 4.65%
Credit card rates View more rates
Card type Today +/- Last Week
Low Interest Cards 13.34%
13.32%
Cash Back Cards 17.82%
17.81%
Rewards Cards 17.07%
17.06%
Source: Bankrate.com